Business Insights: Page 3

Siemens Healthineers to close Fast Track Diagnostics unit
By LabPulse.com staff writers
Siemens Healthineers intends to close its Fast Track Diagnostics unit by September 2024.
March 19, 2024
Business Economics Pie Chart2 Social
Oxford Nanopore, SeqOne to collaborate on sequencing platform
By LabPulse.com staff writers
Oxford Nanopore and genomics firm SeqOne are collaborating on an end-to-end platform for whole-genome nanopore sequencing reads for clinical diagnostic testing.
March 18, 2024
Dna Sequencing Data Analysis Social
NGeneBio, Genolution to collaborate on automated NGS system
By LabPulse.com staff writers
Precision diagnostics company NGeneBio and molecular diagnostics firm Genolution have signed a memorandum of understanding to develop and launch an automated next-generation sequencing (NGS) system.
March 14, 2024
Business Handshake Intelligence Social
FDA updates draft guidance for Alzheimer's drug development biomarkers
By LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) has released an updated draft guidance for the use of biomarkers aimed at sponsors and pharmaceutical companies developing drugs intended to treat early Alzheimer's disease.
March 14, 2024
Amyloid Plaque Alzheimer Social
Zephyr AI closes $111M series A funding round
By LabPulse.com staff writers
Biotech startup Zephyr AI announced on Wednesday that it successfully closed a $111 million series A funding round.
March 13, 2024
Artificial Intelligence Drug Design Funding Social
Bluebird Bio signs state Medicaid agreement for SCD gene therapy
By LabPulse.com staff writers
Bluebird Bio has signed its first outcomes-based Medicaid agreement for its sickle-cell disease (SCD) gene therapy Lyfgenia with the state of Michigan.
March 11, 2024
Sickle Cell Anemia2 Social
T2 Biosystems granted Nasdaq listing extension
By LabPulse.com staff writers
Nasdaq's Hearings Panel has granted T2 Biosystems' request for an extension for continued listing on the stock market subject to T2 complying with Nasdaq's rule for market value of listed securities.
March 12, 2024
Earning Stock Market Social
Patient Square Capital to acquire NanoString assets for $220M
By LabPulse.com staff writers
NanoString Technologies has reached a binding agreement with Patient Square Capital in which NanoString will sell substantially all of its assets to the investment firm for $220 million.
March 11, 2024
Business Agreement Social
Ginkgo Bioworks launches technology network
By Matt Limb
Ginkgo Bioworks has launched a new technology network with 25 partners, pledging to improve customers’ research and development outcomes.
March 6, 2024
Global Collaboration Business Social
MD Anderson Cancer Center acquires cell therapy switch technologies
By Matt Limb
The University of Texas MD Anderson Cancer Center has acquired inducible switch technologies for development in cell therapy programs from Bellicum Pharmaceuticals.
March 7, 2024
Cell Analysis Therapy Engineering Social
Eisai invests $15M in C2N to increase Alzheimer's test access
By LabPulse.com staff writers
C2N Diagnostics has announced that pharmaceutical company Eisai has agreed to invest up to $15 million in C2N to provide broader access to Alzheimer’s disease tests.
March 6, 2024
Amyloid Plaque Alzheimer2 Social
Ibex, PathPresenter ink partnership
By LabPulse.com staff writers
Ibex Medical Analytics (Ibex) and PathPresenter announced a partnership to enable wider use of AI-enabled digital pathology for their joint customers.
March 6, 2024
Hands Shaking2 Social
Previous Page
Page 3 of 177
Next Page